BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34657447)

  • 1. Knockdown of long noncoding RNA AC245100.4 inhibits the tumorigenesis of prostate cancer cells via the STAT3/
    Liu C; Lin P; Zhao J; Xie H; Li R; Yang X; Wang N; Jia H; Jiang S; Zhang K; Yu X
    Epigenomics; 2021 Oct; 13(20):1591-1605. PubMed ID: 34657447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non‑coding RNA AC245100.4 promotes prostate cancer tumorigenesis via the microRNA‑145‑5p/RBBP5 axis.
    Xie H; Zhao J; Wan J; Zhao J; Wang Q; Yang X; Yang W; Lin P; Yu X
    Oncol Rep; 2021 Feb; 45(2):619-629. PubMed ID: 33416179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA BRE-AS1 represses non-small cell lung cancer cell growth and survival via up-regulating NR4A3.
    Zhang M; Wu J; Zhong W; Zhao Z; Liu Z
    Arch Biochem Biophys; 2018 Dec; 660():53-63. PubMed ID: 30227111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA AC245100.4 contributes to prostate cancer migration via regulating PAR2 and activating p38-MAPK pathway.
    Liu C; Jiang S; Xie H; Jia H; Li R; Zhang K; Wang N; Lin P; Yu X
    Med Oncol; 2022 May; 39(5):94. PubMed ID: 35570225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA LINC00467 drives hepatocellular carcinoma progression via inhibiting NR4A3.
    Wang H; Guo Q; Nampoukime KB; Yang P; Ma K
    J Cell Mol Med; 2020 Apr; 24(7):3822-3836. PubMed ID: 32125766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA
    Cui R; Liu C; Lin P; Xie H; Wang W; Zhao J; Jiang S; Shi J; Yu X
    Epigenomics; 2020 Aug; 12(15):1257-1271. PubMed ID: 32811161
    [No Abstract]   [Full Text] [Related]  

  • 7. Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer.
    Yeh CM; Chang LY; Lin SH; Chou JL; Hsieh HY; Zeng LH; Chuang SY; Wang HW; Dittner C; Lin CY; Lin JM; Huang YT; Ng EK; Cheng AS; Wu SF; Lin J; Yeh KT; Chan MW
    Sci Rep; 2016 Aug; 6():31690. PubMed ID: 27528092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RP11-495P10.1 promotes HCC cell proliferation by regulating reprogramming of glucose metabolism and acetylation of the NR4A3 promoter via the PDK1/PDH axis.
    Liu C; Shi J; Jiang Z; Jiang S; Wu Y; Peng D; Tang J; Guo L
    Acta Biochim Biophys Sin (Shanghai); 2024 Jan; 56(1):44-53. PubMed ID: 37905340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional Profiling of Monocytes Deficient in Nuclear Orphan Receptors
    Phelan DE; Shigemura M; Aldhafiri S; Mota C; Hall TJ; Sznajder JI; Murphy EP; Crean D; Cummins EP
    Front Immunol; 2021; 12():676644. PubMed ID: 34248958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis.
    Fedorova O; Petukhov A; Daks A; Shuvalov O; Leonova T; Vasileva E; Aksenov N; Melino G; Barlev NA
    Oncogene; 2019 Mar; 38(12):2108-2122. PubMed ID: 30455429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer.
    Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY
    Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis.
    Lin HY; Ko CJ; Lo TY; Wu SR; Lan SW; Huang CA; Lin YC; Lin HH; Tu HF; Lee CF; Hsiao PW; Huang HP; Chen MJ; Chang KH; Lee MS
    Oncogene; 2022 May; 41(20):2833-2845. PubMed ID: 35418692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-8 Secreted from M2 Macrophages Promoted Prostate Tumorigenesis via STAT3/MALAT1 Pathway.
    Zheng T; Ma G; Tang M; Li Z; Xu R
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30591689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA AC245100.4 activates the PI3K/AKT pathway to promote PCa cell proliferation by elevating PAR2.
    Zhang K; Liu C; Hu C; Lin P; Qi Q; Jia H; Tang J; Yu X
    Heliyon; 2023 Jun; 9(6):e16870. PubMed ID: 37346322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway.
    Sun X; Xin S; Zhang Y; Jin L; Liu X; Zhang J; Mei W; Zhang B; Ma W; Ye L
    Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35904175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective role of NR4A3 in acute myocardial infarction by suppressing inflammatory responses via JAK2-STAT3/NF-κB pathway.
    Jiang Y; Feng YP; Tang LX; Yan YL; Bai JW
    Biochem Biophys Res Commun; 2019 Oct; 517(4):697-702. PubMed ID: 31399192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy in combination with hyperthermia suppresses lung cancer progression via increased NR4A3 and KLF11 expression.
    Son B; Jeon J; Lee S; Kim H; Kang H; Youn H; Jo S; Youn B
    Int J Radiat Biol; 2019 Dec; 95(12):1696-1707. PubMed ID: 31498019
    [No Abstract]   [Full Text] [Related]  

  • 18. The Orphan Nuclear Receptor NR4A3 Is Involved in the Function of Dendritic Cells.
    Nagaoka M; Yashiro T; Uchida Y; Ando T; Hara M; Arai H; Ogawa H; Okumura K; Kasakura K; Nishiyama C
    J Immunol; 2017 Oct; 199(8):2958-2967. PubMed ID: 28893954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis.
    Hao T; Wang Z; Yang J; Zhang Y; Shang Y; Sun J
    Biomed Pharmacother; 2020 Mar; 123():109666. PubMed ID: 31935634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas.
    Brenca M; Stacchiotti S; Fassetta K; Sbaraglia M; Janjusevic M; Racanelli D; Polano M; Rossi S; Brich S; Dagrada GP; Collini P; Colombo C; Gronchi A; Astolfi A; Indio V; Pantaleo MA; Picci P; Casali PG; Dei Tos AP; Pilotti S; Maestro R
    J Pathol; 2019 Sep; 249(1):90-101. PubMed ID: 31020999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.